Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Bridges Investment Management Inc.

Bridges Investment Management Inc. lessened its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 25.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 570 shares of the biotechnology company’s stock after selling 199 shares during the quarter. Bridges Investment Management Inc.’s holdings in Axon Enterprise were worth $339,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Prestige Wealth Management Group LLC increased its position in Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares in the last quarter. New Wave Wealth Advisors LLC acquired a new stake in Axon Enterprise during the 4th quarter worth approximately $40,000. Brooklyn Investment Group acquired a new stake in Axon Enterprise during the 3rd quarter worth approximately $41,000. Y.D. More Investments Ltd acquired a new stake in Axon Enterprise during the 4th quarter worth approximately $45,000. Finally, Planning Capital Management Corp increased its position in Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON opened at $525.75 on Tuesday. The business’s fifty day moving average price is $607.58 and its 200 day moving average price is $526.43. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The stock has a market capitalization of $40.09 billion, a PE ratio of 135.85, a price-to-earnings-growth ratio of 5.17 and a beta of 1.05. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Wall Street Analyst Weigh In

AXON has been the subject of several recent research reports. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price objective for the company. in a research report on Thursday, February 20th. TD Cowen initiated coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective for the company. The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. Barclays set a $726.00 price objective on shares of Axon Enterprise and gave the company an “overweight” rating in a research report on Thursday. Finally, Northland Securities increased their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $587.38.

Insider Buying and Selling

In related news, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the transaction, the director now directly owns 24,259 shares in the company, valued at $15,518,239.71. This trade represents a 3.96 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the firm’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the transaction, the director now owns 2,392 shares in the company, valued at $1,631,487.52. This trade represents a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 6,407 shares of company stock worth $4,122,925 over the last ninety days. 6.10% of the stock is owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.